← Leaderboards
Uma Sankar
Indiana University Indianapolis
$5,047,260
Attributed
$5,047,260
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $838.4K · FY2015–24$1M$750K$500K$250K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$5,047,260 · 2
By mechanism
R01$5,047,260 · 2
Top collaborators
No co-investigators on record.
Most similar at Indiana University Indianapolis
Same institution · by research overlap
- Lilian Irene Plotkin$4,369,022
- Ping Zhang$225,745
- Evan L Fogel$7,933,802
Others in their field
Top investigators on “Bone Remodeling”
- Michael L. Terrin · Clinical Trials And Surveys Corporation$23,217,528
- Caroline M. Tanner · Parkinson'S Institute$16,300,213
- Steven R Cummings · University Of California San Francisco$16,300,213
- Xu Cao · Johns Hopkins University$16,259,700
- Gerard Karsenty · University Of Texas Md Anderson Can Ctr$14,954,330
- Elizabeth J. Shane · Mayo Clinic Rochester$12,642,475
Research focus
Bone RemodelingGenerationsMediatingTherapeutic TargetSignal TransductionKnockout MiceFamily MemberPathway InteractionsOsteoclastsOsteoblastsPlayPhosphotransferasesOperative Surgical ProceduresRegulationCa(2+)-Calmodulin Dependent Protein KinaseCellsInvestigationSignal PathwayInnovationProtein KinaseBasePharmacologyMacrophageOverexpression
Grant awards (13)
CaMKK2 Signaling in Osteoarthritis$514,679
R01 · FY2024 · AR · contact PI
CaMKK2 Signaling in Osteoarthritis$530,597
R01 · FY2023 · AR · contact PI
CaMKK2 Signaling in Osteoarthritis$525,291
R01 · FY2022 · AR · contact PI
CaMKK2 Signaling in Osteoarthritis$524,543
R01 · FY2021 · AR · contact PI
CaMKK2 Signaling in Osteoarthritis$313,889
R01 · FY2021 · AR · contact PI
CaMKK2 Signaling in Osteoarthritis$563,023
R01 · FY2020 · AR · contact PI
CaMKK2 Inhibition as a Dual-Action Bone Anabolic and Anti-Catabolic Therapy in Osteoporosis$340,428
R01 · FY2019 · AR · contact PI
CaMKK2 Inhibition as a Dual-Action Bone Anabolic and Anti-Catabolic Therapy in Osteoporosis$151,385
R01 · FY2019 · AR · contact PI
CaMKK2 Inhibition as a Dual-Action Bone Anabolic and Anti-Catabolic Therapy in Osteoporosis$340,428
R01 · FY2018 · AR · contact PI
CaMKK2 Inhibition as a Dual-Action Bone Anabolic and Anti-Catabolic Therapy in Osteoporosis$438,670
R01 · FY2017 · AR · contact PI
CaMKK2 Inhibition as a Dual-Action Bone Anabolic and Anti-Catabolic Therapy in Osteoporosis$450,823
R01 · FY2016 · AR · contact PI
CaMKK2 Inhibition as a Dual-Action Bone Anabolic and Anti-Catabolic Therapy in Osteoporosis$16,218
R01 · FY2016 · AR · contact PI
CaMKK2 Inhibition as a Dual-Action Bone Anabolic and Anti-Catabolic Therapy in Osteoporosis$337,286
R01 · FY2015 · AR · contact PI